Dengue Hemorrhagic Fever (DHF) is a mosquito-borne infection and characterized by spontaneous hemorrhage with thrombocytopenia. The infection is observed from childhood among South-East Asian countries and has become problems. The male and female patients with DHF stageII (average age: 7.92 years old) were given 2 capsules of OM-X a day. We observed statistically significant improvements, including the regulation of hematocrit levels and the increment of blood platelet counts. No aggravation of symptoms were found.
Last updated 2019/06/06